Research interests include Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Brain Metastases and Treatment, and Lung Cancer Research Studies.
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
The Lancet Oncology2016cited by 994position: middledoi
Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases.
Journal of Clinical Oncology2015cited by 33position: middledoi